Skip to main content
. 2022 Nov 19;19:277. doi: 10.1186/s12974-022-02635-3

Fig. 1.

Fig. 1

Individualized fingolimod treatment accelerates disease recovery and decrease the histopathological damage in EAE mice. A Individualized fingolimod treatment from disease onset significantly reduced the clinical course and severity of EAE in mice (EAE-Veh N = 19; EAE-FTY720 N = 18). B, C Panoramic images of the spinal cord of one EAE-Veh (B) and one EAE-FTY720 (C) mouse stained with EC (myelin, blue). Dashed lines define the demyelinated area. D, E Detailed view of SMI-32 staining (axonal damage, red) in infiltrated areas (delimitated by dashed lines) of the spinal cord of EAE-Veh (D) and EAE-FTY720 (E) mice (nuclei are stained with Hoechst). F, G Quantification of the relative demyelination within the white matter or the axonal damage within the infiltrated area in the histological sub-cohort of EAE mice (EAE-Veh N = 9, EAE-FTY720 N = 9). Scale bar: B, C = 250 µm; D, E = 50 µm